Liberty Biopharma (CVE:LTY) Shares Break Above 50-Day Moving Average – Here’s Why

Liberty Biopharma Inc (CVE:LTY – Get Free Report) passed above its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of C$2.00 and traded as high as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares trading hands.

Liberty Biopharma Trading Up ∞

The business has a 50 day moving average of C$2.00 and a 200 day moving average of C$2.00. The firm has a market capitalization of C$21.54 million and a price-to-earnings ratio of -12.66. The company has a debt-to-equity ratio of 8.19, a current ratio of 0.12 and a quick ratio of 0.12.

About Liberty Biopharma

(Get Free Report)

Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.

Featured Articles

• Five stocks we like better than Liberty Biopharma
• Costco Ends Its Fiscal Year on a High Note, Eyes Big Expansion
• Cracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic Problem
• Oracle’s Force Majeure Notice Exposes a Bigger Problem for the AI Build-Out
• Oil May Be Stronger Than It Looks—And Diamondback Is on Sale